270 related articles for article (PubMed ID: 25819361)
1. Dextrin-coated zinc substituted cobalt-ferrite nanoparticles as an MRI contrast agent: In vitro and in vivo imaging studies.
Sattarahmady N; Zare T; Mehdizadeh AR; Azarpira N; Heidari M; Lotfi M; Heli H
Colloids Surf B Biointerfaces; 2015 May; 129():15-20. PubMed ID: 25819361
[TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic cobalt ferrite nanoparticles as
Mohammadi Z; Attaran N; Sazgarnia A; Shaegh SAM; Montazerabadi A
IET Nanobiotechnol; 2020 Jul; 14(5):396-404. PubMed ID: 32691742
[TBL] [Abstract][Full Text] [Related]
3. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
Shan X; Yuan D; Xiong F; Gu N; Wang P
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
[TBL] [Abstract][Full Text] [Related]
4. The impact of silica encapsulated cobalt zinc ferrite nanoparticles on DNA, lipids and proteins of rat bone marrow mesenchymal stem cells.
Novotna B; Turnovcova K; Veverka P; Rössner P; Bagryantseva Y; Herynek V; Zvatora P; Vosmanska M; Klementova M; Sykova E; Jendelova P
Nanotoxicology; 2016 Aug; 10(6):662-70. PubMed ID: 26581309
[TBL] [Abstract][Full Text] [Related]
5. Synergetic effect of size and morphology of cobalt ferrite nanoparticles on proton relaxivity.
N V; Srivastava C; Hegde V
IET Nanobiotechnol; 2014 Dec; 8(4):184-9. PubMed ID: 25429495
[TBL] [Abstract][Full Text] [Related]
6. Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.
Chaudhary R; Roy K; Kanwar RK; Walder K; Kanwar JR
J Nanobiotechnology; 2016 Jan; 14():6. PubMed ID: 26775253
[TBL] [Abstract][Full Text] [Related]
7. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
8. Cobalt nanoparticles as a novel magnetic resonance contrast agent--relaxivities at 1.5 and 3 Tesla.
Parkes LM; Hodgson R; Lu le T; Tung le D; Robinson I; Fernig DG; Thanh NT
Contrast Media Mol Imaging; 2008; 3(4):150-6. PubMed ID: 18756588
[TBL] [Abstract][Full Text] [Related]
9. Engineered Polyethylene Glycol-Coated Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent.
Dabagh S; Haris SA; Ertas YN
ACS Biomater Sci Eng; 2023 Jul; 9(7):4138-4148. PubMed ID: 37311018
[TBL] [Abstract][Full Text] [Related]
10. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic resonance imaging.
Yang H; Zhang C; Shi X; Hu H; Du X; Fang Y; Ma Y; Wu H; Yang S
Biomaterials; 2010 May; 31(13):3667-73. PubMed ID: 20144480
[TBL] [Abstract][Full Text] [Related]
12. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging.
Yuk SH; Oh KS; Cho SH; Lee BS; Kim SY; Kwak BK; Kim K; Kwon IC
Biomacromolecules; 2011 Jun; 12(6):2335-43. PubMed ID: 21506550
[TBL] [Abstract][Full Text] [Related]
13. Hydrothermal synthesis of a highly sensitive T2-weigthed MRI contrast agent: zinc-doped superparamagnetic iron oxide nanocrystals.
Chen F; Bu W; Lu C; Chen G; Chen M; Shen X; Liu R; Shi J
J Nanosci Nanotechnol; 2011 Dec; 11(12):10438-43. PubMed ID: 22408922
[TBL] [Abstract][Full Text] [Related]
14. Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging.
Kevadiya BD; Bade AN; Woldstad C; Edagwa BJ; McMillan JM; Sajja BR; Boska MD; Gendelman HE
Acta Biomater; 2017 Feb; 49():507-520. PubMed ID: 27916740
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
[TBL] [Abstract][Full Text] [Related]
17. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging.
Billotey C; Wilhelm C; Devaud M; Bacri JC; Bittoun J; Gazeau F
Magn Reson Med; 2003 Apr; 49(4):646-54. PubMed ID: 12652535
[TBL] [Abstract][Full Text] [Related]
18. An aqueous method for the controlled manganese (Mn(2+)) substitution in superparamagnetic iron oxide nanoparticles for contrast enhancement in MRI.
Ereath Beeran A; Nazeer SS; Fernandez FB; Muvvala KS; Wunderlich W; Anil S; Vellappally S; Ramachandra Rao MS; John A; Jayasree RS; Varma PR
Phys Chem Chem Phys; 2015 Feb; 17(6):4609-19. PubMed ID: 25586703
[TBL] [Abstract][Full Text] [Related]
19. Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging.
Li Z; Wang SX; Sun Q; Zhao HL; Lei H; Lan MB; Cheng ZX; Wang XL; Dou SX; Max Lu GQ
Adv Healthc Mater; 2013 Jul; 2(7):958-64. PubMed ID: 23322490
[No Abstract] [Full Text] [Related]
20. Synthetic antiferromagnetic nanoparticles as potential contrast agents in MRI.
Van Roosbroeck R; Van Roy W; Stakenborg T; Trekker J; D'Hollander A; Dresselaers T; Himmelreich U; Lammertyn J; Lagae L
ACS Nano; 2014 Mar; 8(3):2269-78. PubMed ID: 24483137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
